Clinical Trial Update: A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for HS-20137 in participants with moderate-to-severe plaque psoriasis; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• HS-20137

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Moderate-to-severe Plaque Psoriasis | Phase 3 | Status: NOT_YET_RECRUITING